Working with healthcare professionals and patients
We are committed to transparency. Therefore, we disclose the transfers of value we make to individual healthcare professionals and patients and to their respective organizations. We work with healthcare professionals and patient organizations to deliver new treatment options within brain diseases and our interactions are well-regulated.
To develop and deliver innovative treatment of brain disease, we work with a range of stakeholders. These include healthcare professionals, patients and their respective organizations. We collaborate on research, clinical development, exchange of scientific information, and marketing and sales activities.
These interactions are well-regulated by the national laws and industry association regulations that we integrate into our working processes, training and guidance.
We are committed to transparency and our disclosed information follows the current laws or regulations from the industry associations we have joined, such as the European Federation of Pharmaceutical Industries and Associations (EFPIA).
According to the Ethical rules for dialogue and negotiations with decision-makers published by Danish Ethical Committee for the Pharmaceutical Industry, every pharmaceutical company is obliged to publish a schedule on their website with the names of the PR or communication agencies, legal counsel or similar external consultancies acting on behalf of the pharmaceutical company to engage in dialogue and negotiations with decision-makers.
The following external consultants are representing H. Lundbeck A/S in dialogue and negotiation with decision makers:
Rud Pedersen Public Affairs
Christians Brygge 24, 3.
DK- 1559 København V
Lead Agency
Ravnsborg Tværggade 5c, 1.
DK-2200 København N
We have made the external agencies aware of the present set of rules and that the pharmaceutical company accepts responsibility for ensuring third party compliance therewith.
Here you can find an overview, together with the locations, of Lundbeck’s interactions with healthcare professionals and the related transfers of value:
Country | 2021 | 2022 | 2023 | |||
Bulgaria | PDF |
|||||
Croatia | ||||||
Hungary | PDF |
|||||
Ukraine | PDF |
|||||
United Kingdom | Patient organisations
Methodological notes for patient organization disclosures |
Patient organisations
Methodological notes for patient organization disclosures
Public*
Methodological notes for public* disclosures
|
Patient organisations
Methodological notes for patient organization disclosures
Public*
Methodological notes for public* disclosures |
|||
*including patients and journalists |
Lundbeck discloses payments and other transfers for value to HCPs and HCOs in aggregate, if the HCP or HCO has used their legal right to refuse consent to individual disclosure, in accordance with the EFPIA Disclosure Code. The data covers Lundbeck affiliates that use Lundbeck’s corporate website for disclosure. Data from other countries can be found on the Country overview tab.
Lundbeck undertakes research activities and conducts clinical studies globally. Clinical studies are conducted in accordance with international guidelines and performed by HCPs and HCOs. Our payments and other transfers of value related to pre-clinical, clinical and non-interventional studies are disclosed in aggregate.
Country | 2020 | 2021 |
Bulgaria | €745,539 | €403,565 |
Croatia | €5,101 | - |
Estonia | - |
- |
Hungary | €52,343 | €46,635 |
Latvia | - |
- |
Lithuania | - |
- |
Ukraine | €413,939 | €232,245 |
The amounts cover payments and other transfers of value to HCPs and HCOs related to pre-clinical, clinical and non-interventional studies in the countries where the Lundbeck affiliate uses Lundbeck’s corporate website for disclosure in accordance with the EFPIA Disclosure Code.
Data from other countries can be found under countries that disclose.
More from Lundbeck
Responsible business conduct
We pursue our business purpose guided by several pillars and our Code of Conduct.
Clinical data sharing
Our policy for scientific publications and responsible clinical data sharing.
Patients
We see patients as people and are committed to support the person behind.